Otsuka Holdings Co (FRA:OS1) NonCurrent Deferred Revenue: €121 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:OS1 Otsuka Holdings Co Ltd FRA:OS1
87 GF Score
Price €64.50
GF Value €48.97
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Otsuka Holdings Co NonCurrent Deferred Revenue?

Otsuka Holdings Co FRA:OS1 -0.77% 87 NonCurrent Deferred Revenue is €121 Mil as of Jun. 2026. GuruFocus rates FRA:OS1 with a GF Score™ of 87/100 and a GF Value™ of €48.97 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Non-Current Deferred Revenue represents the non-current portion of deferred revenue amount as of the balance sheet date. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months.

Otsuka Holdings Co's non-current deferred revenue for the quarter that ended in Jun. 2026 was €121 Mil.

Otsuka Holdings Co NonCurrent Deferred Revenue Related Terms

Otsuka Holdings Co NonCurrent Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Otsuka Holdings Co's NonCurrent Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otsuka Holdings Co NonCurrent Deferred Revenue Chart

Otsuka Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 449.14 355.00 285.77 219.55 142.55

Otsuka Holdings Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
NonCurrent Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 184.83 166.63 142.55 131.43 121.25
FRA:OS1
87GF Score
Otsuka Holdings Co Ltd FRA:OS1
NonCurrent Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Revenue of €121 Mil mean?
Otsuka Holdings Co (FRA:OS1) has a NonCurrent Deferred Revenue of €121 Mil as of Jun. 2026. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Otsuka Holdings Co and its competitors.
Is Otsuka Holdings Co's NonCurrent Deferred Revenue too high?
Otsuka Holdings Co's current NonCurrent Deferred Revenue is €121 Mil. Overall, Otsuka Holdings Co has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Otsuka Holdings Co's NonCurrent Deferred Revenue compare to LLY and JNJ?
Otsuka Holdings Co's NonCurrent Deferred Revenue of €121 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Revenue for a Drug Manufacturers company?
A good NonCurrent Deferred Revenue depends on the Drug Manufacturers industry context. However, NonCurrent Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Revenue mean?
A high NonCurrent Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Otsuka Holdings Co and its competitors. Otsuka Holdings Co's current NonCurrent Deferred Revenue is €121 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otsuka Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Otsuka Holdings Co (FRA:OS1) is currently considered Significantly Overvalued. The stock's GF Value™ is €48.97, compared to a current price of €64.50 — trading 31.7% above its estimated fair value. The current NonCurrent Deferred Revenue is €121 Mil. Otsuka Holdings Co's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Revenue calculated?
NonCurrent Deferred Revenue is calculated from a company's financial statements. For Otsuka Holdings Co (FRA:OS1), the current NonCurrent Deferred Revenue is €121 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Otsuka Holdings Co (FRA:OS1) Overvalued in 2026?

Based on GuruFocus' analysis, Otsuka Holdings Co stock appears to be overvalued. The current stock price of €64.50 is trading 31.7% above its estimated GF Value™ of €48.97. GuruFocus considers Otsuka Holdings Co to be Significantly Overvalued.

Key valuation signals for FRA:OS1:

  • NonCurrent Deferred Revenue: €121 Mil
  • GF Value™: €48.97 vs. price of €64.50 (31.7% above fair value)
  • GF Score™: 87/100 with 4 warning signs

No single metric tells the full story. See the FRA:OS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Otsuka Holdings Co Business Description

Address 2-16-4 Konan, Shinagawa Grand Central Tower, Minato-ku, Tokyo, JPN, 108-8241
Otsuka Holdings Co Ltd is a Japan-based company that operates in pharmaceuticals, nutraceuticals, and consumer products. It operates through four reportable segments: Medical-related Business, Nutraceutical-related Business, Consumer-related Business, and Other Business. The Medical Business manufactures and sells therapeutic drugs and infusions, the Nutraceutical Business produces functional foods, beverages, and nutritional supplements, the Consumer Business offers mineral water, beverages, and foods, while the Other Business provides storage services and manufactures chemicals and analytical equipment. It generates the majority of its revenue from the medical-related business segment.
87GF Score

Get the complete analysis for FRA:OS1

NonCurrent Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€64.50
Price
€48.97
GF Value